COVID-19 Associated Pulmonary Thromboembolic Events in Anti-Coagulated Patients: Case Series from a Tertiary Facility in Ghana

Abstract

Severe/critical Coronavirus Virus Disease 2019 (COVID-19) patients face increased risk of pulmonary embolism (PE) and other thromboembolic events. This risk exists even in patients who are on prophylactic and therapeutic doses of anticoagulant. We present three cases of Severe/critical COVID-19 patients who developed PE despite being placed on prophylactic doses of anticoagulants. Clinicians should be keenly aware of this and urgently institute appropriate diagnostic measures if PE is suspected